Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
MIRA Pharmaceuticals, Inc. (MIRA) had Pre-Tax Income of $-7.85M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-7.85M |
|
-- |
|
-- |
|
$8.02M |
|
$-8.02M |
|
$0.17M |
|
|
Pre-Tax Income |
$-7.85M |
$-7.85M |
|
$-7.85M |
|
$-7.85M |
|
$-7.85M |
|
$-7.85M |
|
$-8.02M |
|
$-8.02M |
|
15.44M |
|
15.44M |
|
$-0.51 |
|
$-0.51 |
|
| Balance Sheet Financials | |
$2.89M |
|
-- |
|
$0.04M |
|
$2.92M |
|
$0.72M |
|
-- |
|
-- |
|
$0.72M |
|
$2.20M |
|
$2.20M |
|
$2.20M |
|
16.56M |
|
| Cash Flow Statement Financials | |
$-5.56M |
|
-- |
|
$3.79M |
|
$4.60M |
|
$2.83M |
|
$-1.77M |
|
$1.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.99 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.56M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-356.98% |
|
-356.98% |
|
-268.64% |
|
-356.98% |
|
$0.13 |
|
$-0.36 |
|
$-0.36 |
|